PMC:7441788 / 37496-37914
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T150 | 23-31 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T272 | 186-188 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T273 | 208-209 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T274 | 262-264 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T275 | 323-325 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T276 | 399-401 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | ms |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T383 | 142-154 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T384 | 301-313 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T220 | 142-154 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T221 | 301-313 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T136 | 23-31 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T257 | 0-418 | Sentence | denotes | Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1347 | 32-40 | Species | denotes | patients | Tax:9606 |
1348 | 103-111 | Species | denotes | patients | Tax:9606 |
1349 | 193-201 | Species | denotes | patients | Tax:9606 |
1350 | 271-279 | Species | denotes | patients | Tax:9606 |
1373 | 122-125 | Chemical | denotes | HCQ | MESH:D006886 |
1374 | 142-154 | Chemical | denotes | azithromycin | MESH:D017963 |
1375 | 293-296 | Chemical | denotes | HCQ | MESH:D006886 |
1376 | 301-313 | Chemical | denotes | azithromycin | MESH:D017963 |
1377 | 353-356 | Chemical | denotes | HCQ | MESH:D006886 |
1414 | 23-31 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T143 | 23-31 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1347 | 32-40 | Species | denotes | patients | Tax:9606 |
1348 | 103-111 | Species | denotes | patients | Tax:9606 |
1349 | 193-201 | Species | denotes | patients | Tax:9606 |
1350 | 271-279 | Species | denotes | patients | Tax:9606 |
1373 | 122-125 | Chemical | denotes | HCQ | MESH:D006886 |
1374 | 142-154 | Chemical | denotes | azithromycin | MESH:D017963 |
1375 | 293-296 | Chemical | denotes | HCQ | MESH:D006886 |
1376 | 301-313 | Chemical | denotes | azithromycin | MESH:D017963 |
1377 | 353-356 | Chemical | denotes | HCQ | MESH:D006886 |
1414 | 23-31 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T257 | 0-418 | Sentence | denotes | Another observation in COVID-19 patients admitted to ICU showed that QTc intervals increased in 93% of patients receiving HCQ with or without azithromycin, prolonged QTc was observed in 36% of patients after a duration of the treatment for 2 to 5 days, and 6 of 18 (33%) patients treated with HCQ and azithromycin and 1 of 22 (5%) of those treated with HCQ alone developed an increase in QTc of 500 ms or greater [69]. |